Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • OAT
    (10)
  • Xanthine Oxidase
    (2)
  • PDE
    (1)
  • TAM Receptor
    (1)
  • transporter
    (1)
  • Others
    (11)
Filter
Search Result
Results for "

urat1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    29
    TargetMol | Inhibitors_Agonists
  • Natural Products
    1
    TargetMol | Natural_Products
URAT1 inhibitor 7
T775171632002-28-8
URAT1 inhibitor 7 is a novel and potent inhibitor of the human uric acid transporter protein URAT1 (IC50:12 nM).URAT1 inhibitor 7 inhibits CYP2C9 with an IC50 of 4.2 μM.URAT1 inhibitor 7 can be used to study hyperuricemia and gout.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Epaminurad HCl
URC-102 HCl, UR-1102 HCl, Epaminurad HCl(1198153-15-9 Free base)
T27275L1198153-46-6In house
Epaminurad HCl is a URAT1 inhibitor with partial inhibition of OAT1 and OAT3 (organic anion transporters).Epaminurad HCl is a pro-uric acid excretory agent used for the prevention and treatment of gout and hyperuricemia.
  • Inquiry Price
Size
QTY
Puliginurad
YL-90148
T610482013582-27-7
Puliginurad (YL-90148) is a potent and selective inhibitor of the urate transporter protein (URAT), effectively inhibiting uric acid reabsorption. It can be utilized for the prevention and treatment of hyperuricemia and gout.
  • Inquiry Price
6-8 weeks
Size
QTY
URAT1 inhibitor 1
T132592268720-62-1
URAT1 inhibitor 1 (1g) is a potent inhibitor of uric acid transporter 1 (URAT1) with an IC50 of 32 nM, and has potential therapeutic applications for treating hyperuricemia associated with gout.
  • Inquiry Price
8-10 weeks
Size
QTY
URAT1&XO inhibitor 3
T2001912089040-93-5
URAT1&XO Inhibitor 3 (compound 27) is an orally effective anti-gout agent targeting XO (IC50: 35 nM) and URAT1 (IC50: 31 nM). This compound exhibits favorable pharmacological and pharmacokinetic (PK) characteristics, as well as in vivo safety.
  • Inquiry Price
3-6 months
Size
QTY
URAT1 inhibitor 11
T2031422416416-13-0
URAT1 inhibitor11 (Compound 7) is a potent URAT1 inhibitor, exhibiting an IC50 of 0.18 μM. It effectively reduces uric acid levels in zebrafish with hyperuricemia induced by Potassium oxonate and Xanthinesodium salt.
  • Inquiry Price
Size
QTY
URAT1 inhibitor 3
T60724
URAT1 inhibitor 3 is a potent, orally active, selective inhibitor of URAT1 (IC50 = 0.8 nM) demonstrating urate-lowering efficacy, suitable for research in gout and hyperuricemia [1].
  • Inquiry Price
10-14 weeks
Size
QTY
URAT1 inhibitor 2
T62825
URAT1 inhibitor 2 is an orally active inhibitor of URAT1 and CYP isozyme with IC50 values of 1.36 μM, 16.97 μM, and 5.22 μM for URAT1-mediated 14C-UA uptake, CYP1A2, and CYP2C9, respectively [URAT1 inhibitor 2 is a promising drug candidate for the study of hyperuricemia and gout].
  • Inquiry Price
10-14 weeks
Size
QTY
URAT1 inhibitor 4
T726322700292-02-8
URAT1 Inhibitor 4, derived from Lesinurad, is a potent, orally active inhibitor of URAT1 with an IC50 value of 7.56 μM, demonstrating greater in vivo urate-lowering efficacy than Lesinurad [1].
  • Inquiry Price
6-8 weeks
Size
QTY
URAT1 inhibitor 8
T781951632005-33-4
URAT1 Inhibitor 8 (example 247) serves as a highly potent inhibitor of URAT1, demonstrating an IC50 value of 0.001 μM. It is applicable in the study of gout [1].
  • Inquiry Price
8-10 weeks
Size
QTY
URAT1 inhibitor 5
T791142102670-94-8
URAT1 Inhibitor 5 (compound 16) serves as a powerful inhibitor of URAT1 and is utilized in hyperuricemia research [1].
  • Inquiry Price
8-10 weeks
Size
QTY
URAT1&XO inhibitor 1
T791752669726-78-5
URAT1&XO Inhibitor 1 (compound 29) serves as a dual inhibitor with IC50 values of approximately 10 μM for URAT1 and 1.01 μM for Xanthine Oxidase. It induces a hypouricemic effect in the potassium oxonate-induced hyperuricemic rat model and is utilized in research pertaining to hyperuricemia [1].
  • Inquiry Price
8-10 weeks
Size
QTY
URAT1 inhibitor 6
T791762244807-49-4
URAT1 inhibitor 6 (Compound 1h), with an IC50 of 35 nM for hURAT1, demonstrates 200-fold and 8-fold greater potency compared to Lesinurad and Benzbromarone, respectively. This compound is utilized in the study of inflammation [1].
  • Inquiry Price
8-10 weeks
Size
QTY
URAT1&XO inhibitor 2
T791771239488-96-0
Compound BDEO (URAT1&XO inhibitor 2) serves as a dual-action inhibitor targeting both xanthine oxidase (XO) and URAT1, demonstrating an IC50 value of 3.3 μM for XO inhibition. It effectively impedes uric acid uptake in HEK293 cells with URAT1 expression, evidenced by a Ki of 0.145 μM. In hyperuricemic mice models, the compound has been shown to reduce serum urate levels and uric acid excretion, indicating potential utility for hyperuricemia research [1].
  • Inquiry Price
6-8 weeks
Size
QTY
URAT1 inhibitor 9
T875962251727-90-7
URAT1 Inhibitor 9 (Compound 24) is utilized in the research of gout and hyperuricemia due to its inhibitory effects on URAT1 [1].
  • Inquiry Price
10-14 weeks
Size
QTY
XOR/URAT1-IN-1
T882302810137-86-9
  • Inquiry Price
10-14 weeks
Size
QTY
hURAT1 inhibitor 1
T200163
Compound 27b, also known as hURAT1 inhibitor 1, is an isomarine-derived, orally active inhibitor that targets both hURAT1 and GLUT9 with IC50 values of 0.16 μM and 4.47 μM, respectively. This compound exhibits significant anti-hyperuricemia effects and has demonstrated potent uric acid-lowering activity in a hyperuricemia mouse model at a dose of 10 mg kg. Importantly, Compound 27b displays no notable in vitro cytotoxicity or in vivo hepatotoxicity, and possesses favorable pharmacokinetic (PK) characteristics.
  • Inquiry Price
Size
QTY
Lingdolinurad
T798542088176-96-7In house
Lingdolinurad is a uric acid transporter protein inhibitor targeting hURAT1 for the study of hyperuricemia or gout.
  • Inquiry Price
8-10 weeks
Size
QTY
Benzarone
Benzarona, Vasoc, Venagil, Benzaronum
T205451477-19-6
Benzarone (Benzarona) is a potent inhibitor of human uric acid transporter 1 (URAT1, IC50 = 2.8 μM in oocyte). Benzarone lowers the level of uric acid serum.
  • Inquiry Price
Size
QTY
Lesinurad
RDEA594
T6875878672-00-5
Lesinurad (RDEA594) is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.
  • Inquiry Price
Size
QTY
Fraxin
Fraxoside, Fraxetin-8-O-glucoside, Paviin
T3783524-30-1
Fraxin (Fraxoside) is a glucoside of fraxetin.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Verinurad
RDEA3170
T39941352792-74-5
Verinurad (RDEA3170) (RDEA3170) is an organic anion transporter URAT1 (SLC22A12) inhibitor for the treatment of gout and hyperuricemia.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Dotinurad
(3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone
T151601285572-51-1
Dotinurad ((3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone) is a potent agent of uricosuric (IC50: 3.6 μM for uric acid).
  • Inquiry Price
Size
QTY
UNC569
UNC 569
T213021350547-65-7
UNC569 (UNC 569) is a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body. It is also a selective uric acid re-absorption inhibitor. UNC569 could normalize the amount of uric acid excreted by gout patients previously classified as under-excretors.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale